Ventilator-associated pneumonia (VAP) is a serious complication related to mechanical ventilation in the neonatal period. However, lack of a specific definition and difficulties obtaining noncontaminated samples of the lower respiratory airway render microbiological diagnosis and etiological treatment extremely difficult. Thus far, only few studies have approached VAP using accepted Centers for Disease Control and Prevention criteria and reliable sampling techniques. In recent years, however, the blind-protected bronchoalveolar lavage technique with protected specimen brush and the development of validated biomarkers have attempted to overcome the diagnostic difficulties and assess the response to therapy. This updated review on neonatal VAP aims to stimulate neonatologists' interest in this subtle but serious complication of mechanical ventilation.

Keywords:
Newborn, Mechanical ventilation, Infections, Pneumonia, Intubation
1.
Fanaroff AA, Stoll BJ, Wright LL, et al: Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147.e141-e148.
2.
Markestad T, Kaaresen PI, Ronnestad A, et al: Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics 2005;115:1289-1298.
3.
Vento M, Cheung PY, Aguar M: The first golden minutes of the extremely-low-gestational-age neonate: a gentle approach. Neonatology 2009;95:286-298.
4.
Miller JD, Carlo WA: Pulmonary complications of mechanical ventilation in neonates. Clin Perinatol 2008;35:273-281, x-xi.
5.
Ambalavanan N, Carlo WA: Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006;30:192-199.
6.
National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-485.
7.
Centers for Disease Control and Prevention: Criteria for defining nosocomial pneumonia. www.cdc.gov/ncidod/hip/NNIS/members/penumonia/Final/PneuCriteriaFinal.pdf (accessed January 17, 2009).
8.
Baltimore RS: The difficulty of diagnosing ventilator-associated pneumonia. Pediatrics 2003;112:1420-1421.
9.
Morris AC, Kefala K, Simpson AJ, et al: Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009;64:516-522.
10.
Cernada M, Aguar M, Brugada M, et al: Ventilator-associated pneumonia in newborn infants diagnosed with an invasive bronchoalveolar lavage technique: a prospective observational study. Pediatr Crit Care Med 2013;14:55-61.
11.
Tripathi SH, Malik GK, Jain A, Kohli N: Study of ventilator associated pneumonia in neonatal intensive care unit: characteristics, risk factors and outcome. Internet J Med Update 2010;5:12-19.
12.
Afjeh SA, Sabzehei MK, Karimi A, Shiva F, Shamshiri AR: Surveillance of ventilator-associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome. Arch Iran Med 2012;15:567-571.
13.
Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ: Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics 2003;112:1283-1289.
14.
Geffers C, Baerwolff S, Schwab F, Gastmeier P: Incidence of healthcare-associated infections in high-risk neonates: results from the German surveillance system for very-low-birthweight infants. J Hosp Infect 2008;68:214-221.
15.
Yuan TM, Chen LH, Yu HM: Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients. J Perinat Med 2007;35:334-338.
16.
Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in pediatric intensive care units in the United States - National Nosocomial Infections Surveillance System. Pediatrics 1999;103:e39.
17.
Gautam A, Ganu SS, Tegg OJ, et al: Ventilator-associated pneumonia in a tertiary paediatric intensive care unit: a 1-year prospective observational study. Crit Care Resusc 2012;14:283-289.
18.
Deng C, Li X, Zou Y, et al: Risk factors and pathogen profile of ventilator-associated pneumonia in a neonatal intensive care unit in China. Pediatr Int 2011;53:332-337.
19.
Tullu MS, Deshmukh CT, Baveja SM: Bacterial nosocomial pneumonia in paediatric intensive care unit. J Postgrad Med 2000;46:18-22.
20.
Stover BH, Shulman ST, Bratcher DF, et al: Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001;29:152-157.
21.
Garland JS: Strategies to prevent ventilator-associated pneumonia in neonates. Clin Perinatol 2010;37:629-643.
22.
Srinivasan R, Asselin J, Gildengorin G, Wiener-Kronish J, Flori HR: A prospective study of ventilator-associated pneumonia in children. Pediatrics 2009;123:1108-1115.
23.
Katayama Y, Minami H, Enomoto M, et al: Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates. J Perinatol 2010;30:270-274.
24.
Thomas W, Speer CP: Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia - what is the evidence? Neonatology 2008;94:150-159.
25.
Dancer SJ, Coyne M, Robertson C, et al: Antibiotic use is associated with resistance of environmental organisms in a teaching hospital. J Hosp Infect 2006;62:200-206.
26.
Sachdev A, Chugh K, Sethi M, et al: Diagnosis of ventilator-associated pneumonia in children in resource-limited setting: a comparative study of bronchoscopic and nonbronchoscopic methods. Pediatr Crit Care Med 2010;11:258-266.
27.
Gauvin F, Lacroix J, Guertin MC, et al: Reproducibility of blind protected bronchoalveolar lavage in mechanically ventilated children. Am J Respir Crit Care Med 2002;165:1618-1623.
28.
Labenne M, Poyart C, Rambaud C, et al: Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit Care Med 1999;27:2537-2543.
29.
Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
30.
el-Ebiary M, Soler N, Monton C, Torres A: Markers of ventilator-associated pneumonia. Clin Intensive Care 1995;6:121-126.
31.
Palazzo SJ, Simpson T, Schnapp L: Biomarkers for ventilator-associated pneumonia: review of the literature. Heart Lung 2011;40:293-298.
32.
Gilbert DN: Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011;52(suppl 4):S346-S350.
33.
Schuetz P, Albrich W, Mueller B: Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011;9:107.
34.
Luyt CE, Combes A, Reynaud C, et al: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008;34:1434-1440.
35.
Oppert M, Reinicke A, Muller C, et al: Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation 2002;53:167-170.
36.
Duflo F, Debon R, Monneret G, et al: Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002;96:74-79.
37.
Zielinska-Borkowska U, Skirecki T, Zlotorowicz M, Czarnocka B: Procalcitonin in early onset ventilator-associated pneumonia. J Hosp Infect 2012;81:92-97.
38.
Conway Morris A, Kefala K, Wilkinson TS, et al: Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 2010;65:201-207.
39.
Ramírez P, Ferrer M, Gimeno R, et al: Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med 2009;37:1691-1695.
40.
Swanson JM, Mueller EW, Croce MA, et al: Changes in pulmonary cytokines during antibiotic therapy for ventilator-associated pneumonia. Surg Infect (Larchmt) 2010;11:161-167.
41.
Determann RM, Millo JL, Gibot S, et al: Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005;31:1495-1500.
42.
Horonenko G, Hoyt JC, Robbins RA, et al: Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007;132:58-63.
43.
Srinivasan R, Song Y, Wiener-Kronish J, Flori HR: Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Pediatr Crit Care Med 2011;12:21-27.
44.
Escobar J, Teramo K, Stefanovic V, et al: Amniotic fluid oxidative and nitrosative stress biomarkers correlate with fetal chronic hypoxia in diabetic pregnancies. Neonatology 2013;103:193-198.
45.
Harwood DT, Nimmo SL, Kettle AJ, Winterbourn CC, Ashby MT: Molecular structure and dynamic properties of a sulfonamide derivative of glutathione that is produced under conditions of oxidative stress by hypochlorous acid. Chem Res Toxicol 2008;21:1011-1016.
46.
Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM: Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology 2010;97:165-174.
47.
Assumma M, Signore F, Pacifico L, et al: Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem 2000;46:1583-1587.
48.
Cernada M, Badia N, Modesto V, et al: Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr 2012;101:e203-e207.
49.
Harwood DT, Darlow BA, Cheah FC, et al: Biomarkers of neutrophil-mediated glutathione and protein oxidation in tracheal aspirates from preterm infants: association with bacterial infection. Pediatr Res 2011;69:28-33.
50.
Raymond J, Aujard Y: Nosocomial infections in pediatric patients: a European, multicenter prospective study - European Study Group. Infect Control Hosp Epidemiol 2000;21:260-263.
51.
Blot S, Rello J, Vogelaers D: What is new in the prevention of ventilator-associated pneumonia? Curr Opin Pulm Med 2011;17:155-159.
52.
Vanlaere I, Libert C: Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 2009;22:224-239, table of contents.
53.
Fischer JE, Allen P, Fanconi S: Delay of extubation in neonates and children after cardiac surgery: impact of ventilator-associated pneumonia. Intensive Care Med 2000;26:942-949.
54.
Elward AM, Warren DK, Fraser VJ: Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics 2002;109:758-764.
55.
Foglia E, Hollenbeak C, Fraser V, Elward A: Costs associated with nosocomial bloodstream infections and ventilator-associated pneumonia in pediatric intensive care unit patients (abstract 109). 16th Annu Meet Soc Healthcare Epidemiol, Chicago, 2006.
56.
Brilli RJ, Sparling KW, Lake MR, et al: The business case for preventing ventilator-associated pneumonia in pediatric intensive care unit patients. Jt Comm J Qual Patient Saf 2008;34:629-638.
57.
Nakwan N, Wannaro J, Thongmak T, et al: Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 2011;46:60-66.
58.
Badr MA, Ali YF, Albanna EA, Beshir MR, Amr GE: Ventilator associated pneumonia in critically-ill neonates admitted to neonatal intensive care unit, Zagazig University Hospitals. Iran J Pediatr 2011;21:418-424.
59.
Foglia E, Meier MD, Elward A: Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients. Clin Microbiol Rev 2007;20:409-425, table of contents.
60.
Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R: Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1-36.
61.
Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC: Prospective randomized controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small children. Br J Anaesth 2009;103:867-873.
62.
Machado MC, Cheng D, Tarquinio KM, Webster TJ: Nanotechnology: pediatric applications. Pediatr Res 2010;67:500-504.
63.
Cordero L, Sananes M, Ayers LW: Comparison of a closed (Trach Care MAC) with an open endotracheal suction system in small premature infants. J Perinatol 2000;20:151-156.
64.
Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV: Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999;159:821-826.
65.
Won SP, Chou HC, Hsieh WS, et al: Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004;25:742-746.
66.
Rogers E, Alderdice F, McCall E, Jenkins J, Craig S: Reducing nosocomial infections in neonatal intensive care. J Matern Fetal Neonatal Med 2010;23:1039-1046.
67.
Ng SP, Gomez JM, Lim SH, Ho NK: Reduction of nosocomial infection in a neonatal intensive care unit (NICU). Singapore Med J 1998;39:319-323.
68.
Yildizdas D, Yapicioglu H, Yilmaz HL: Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J Crit Care 2002;17:240-245.
69.
Ruza F, Alvarado F, Herruzo R, et al: Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Eur J Epidemiol 1998;14:719-727.
70.
Barret JP, Jeschke MG, Herndon DN: Selective decontamination of the digestive tract in severely burned pediatric patients. Burns 2001;27:439-445.
71.
Herruzo-Cabrera R, Garcia Gonzalez JI, Garcia-Magan P, del Rey-Calero J: Nosocomial infection in a neonatal intensive care unit and its prevention with selective intestinal decolonization: a multivariant evaluation of infection reduction. Eur J Epidemiol 1994;10:573-580.
72.
Manzoni P, De Luca D, Stronati M, et al: Prevention of nosocomial infections in neonatal intensive care units. Am J Perinatol 2013;30:81-88.
73.
Gu WJ, Wei CY, Yin RX: Lack of efficacy of probiotics in preventing ventilator-associated pneumonia probiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. Chest 2012;142:859-868.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.